Fresh-stored osteochondral allografts are more desirable than frozen because hyaline cartilage exhibits diminished cell viability and matrix degeneration after freezing. In addition, cartilage resurfacing allows for repair of damaged subchondral bone and provides mature hyaline cartilage, which can increase load-bearing capability compared to fibrocartilage. Over time, the graft allows for incorporation into the patient’s native tissue, which may result in a smooth, functional cartilage surface in the joint. For more information or to speak with an RTI’s customer service representative please contact (800) 624-7238.AllograftInfo.com AllograftInfo.com is an informational website designed to educate patients and the general public about allograft tissue. AllograftInfo.com explores the use of allograft, or human donated tissue, in surgery, as well as provides links to relevant research and articles. The website also addresses several frequently asked questions and provides suggestions on what patients could ask their surgeon when considering allograft. AllograftInfo.com was created to provide patients a convenient and easy-to-understand portal for education on allograft tissue as an available option in a variety of surgeries. About RTI Biologics Inc. RTI Biologics Inc. is a leading provider of sterile biologics implants for surgeries around the world with a commitment to advancing science, safety and innovation. RTI prepares human donated tissue and bovine tissue for transplantation through extensive testing and screening and using proprietary processes. These allograft and xenograft implants are used in orthopedic, dental and other specialty surgeries. RTI’s innovations continuously raise the bar of science and safety for biologics – from being the first company to offer precision-tooled bone implants and assembled technology to maximize each gift of donation, to inventing validated sterilization processes that include viral inactivation steps. The processes – the BioCleanse® Tissue Sterilization Process, Cancelle® SP DBM Sterilization Process and the Tutoplast® Tissue Sterilization Process – have a combined record of millions of implants distributed with zero incidence of allograft-associated infection. These processes have been validated by tissue type to inactivate or remove viruses, bacteria, fungi and spores from the tissue while maintaining biocompatibility and functionality. RTI’s worldwide corporate headquarters are located in Alachua, Fla., with international locations in Germany and France. The company is accredited by the American Association of Tissue Banks in the United States and is a member of AdvaMed.